Role of Cognitive Behavioral Therapy in Fibromyalgia: A Systematic Review
Heloisa Lima Heller1*, Aline Rizzo Borges1, Luís Otávio Amarante Franco1, João Pedro De Oliveira Aucelio1, Marcos Igor Albanaz Vargas1, Rebeca Naoum Lorga1, Mirella Bastos Sales1, Natália Vargas Do Nascimento2, Gabriela Furlan Ribeiro Barbosa Netto2, Beatriz Carneiro Passos1, Beatriz Pires Paes1, Beatriz Toledo Mendes1, Bruna De Paula Gonçalves Sousa Lyra1, Ciro Moisés Oliveira Vieira Dos Santos1, Gustavo Araújo Do Nascimento Santos1, Maria Luiza Pimentel De Oliveira1, Matheus Macêdo Da Silva1, Maurício Silva De Jesus1, Paulo Ricardo Guimaraes Rocha Storni3, Tamires Martinelli De Oliveira Ferraz1, Viviane Cristina Uliana Peterle1, Ana Paula Monteiro Gomides Reis1
1Centro Universitário de Brasília, Brasília, Brazil.
2Universidade Católica de Brasília, Brasília, Brazil.
3Centro Universitário Euro Americano, Brasília, Brazil.
DOI: 10.4236/ojra.2021.114018   PDF   HTML   XML   107 Downloads   528 Views  


A literature search of articles from 2002-2019 was performed using Medline, Embase, Cochrane, LILACS, IBECS, CRD, and Epistemonikos databases, to analyze the effects of Cognitive-Behavioral Therapy (CBT) in the treatment of fibromyalgia. Twenty-seven articles were selected in which CBT was performed exclusively by specialist physicians, associated or not with conventional pharmacological treatment and/or physical exercise. In most articles, CBT worked with self-knowledge and cognitive restructuring, attempting to reduce pain perception, and it showed a general improvement in daily activities by decreasing patient’s limitations, such as morning stiffness. The literature showed significant correlations of CBT in pain processing over time. When CBT was compared to conventional pharmacological therapy, a certain superiority of CBT could be observed concerning the quality of life, catastrophizing, and acceptance of pain. However, when they were simultaneously applied, this improvement in quality of life was not observed.

Share and Cite:

Heller, H. , Borges, A. , Franco, L. , Aucelio, J. , Vargas, M. , Lorga, R. , Sales, M. , Nascimento, N. , Netto, G. , Passos, B. , Paes, B. , Mendes, B. , Lyra, B. , Santos, C. , Santos, G. , Oliveira, M. , Silva, M. , Jesus, M. , Storni, P. , Ferraz, T. , Peterle, V. and Reis, A. (2021) Role of Cognitive Behavioral Therapy in Fibromyalgia: A Systematic Review. Open Journal of Rheumatology and Autoimmune Diseases, 11, 169-187. doi: 10.4236/ojra.2021.114018.

1. Introduction

Fibromyalgia (FM) is a common disease, with a prevalence in the general population that varies between 2% and 8%. Females are the most affected, and the disease can occur in all ages and ethnic groups [1].

It is a complex disorder characterized by generalized chronic pain, predominantly in muscles and soft tissues, although it can extend to any anatomical region [2]. Other symptoms such as fatigue, cognitive complaints, unsatisfactory sleep and mood changes are also present [3]. Such symptoms can directly impact patients’ quality of life, potentially increasing likelihood of developing psychiatric disorders, including depression, anxiety, obsessive-compulsive disorder and post-traumatic stress disorder [4] [5].

Pathogenesis involves biological, psychological, behavioral and social factors. The main characteristics of the pathogenesis of fibromyalgia are related to: 1) changes in central pain modulatory processes in the spinal cord and brain; 2) a prominent role of negative affective factors in the maintenance of pain and disability; 3) a relative lack of efficacy of many pharmacological treatments [2].

Its treatment is based on different therapeutic modalities. The preferred approach is to integrate pharmacological and non-pharmacological resources, involving patients as active agents of this process [1]. The interest in alternative therapy in fibromyalgia is related to unsatisfactory results considering isolated pharmacological therapy [6].

The active participation of patients is essential for a successful treatment. Pharmacological therapies can be useful in relieving symptoms, but patients hardly improve without adopting self-management measures [1], and, in this context, cognitive-behavioral therapy (CBT) is a fundamental tool [7].

Interventions based on the basic premise that chronic pain is sustained by cognitive and behavioral factors are included in CBT. In addition to this, behavioral factors and psychological treatment lead to change through cognitive processes, such as restructuring and behavioral techniques, for example, relaxation and social skills training [8].

CBT presents itself as an important therapeutic resource, as it is capable of modifying patient’s negative thoughts and expectations, improving mood, stress, coping with pain and problem solving, including behavioral interventions that specifically deal with improving the fibromyalgia symptoms (sleep hygiene, relaxation training, activity rhythm) [9].

The present study proposes a systematic review of the literature on the effects of cognitive behavioral therapy in the treatment of fibromyalgia.

2. Methodology

A systematic review was carried out, with retrieval, selection, and critical analysis of results from primary studies in the literature. This study followed the checklist Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) [10], which views amplify the quality of systematic reviews.

Systematic reviews seek to answer a clearly formulated research question in biological and health issues. It was chosen as the structure of the present study because it has well-defined stages and is considered the greatest scientific evidence.

2.1. Eligibility Criteria

Developed based on the acronym PICO, adapting to their respective 4 points:

Population: Patients aged 18 years or over and diagnosed with fibromyalgia (according to the recognized diagnostic criteria) were included in the study.

Intervention: Use of cognitive behavioral therapy in fibromyalgia patients alone or associated with other therapies.

Comparison: Fibromyalgia patients undergoing other types of therapy, another type of treatment, of no treatment at all.

Outcome: All possible outcomes of patients after the use of cognitive behavioral therapy in studies.

2.2. Inclusion and Exclusion Criteria

Inclusion: Portuguese, Spanish and English languages; studies performed in humans; there was no restriction on the year of publication.

Exclusion: studies that did not address CBT, other pain syndromes or other rheumatologic diseases, secondary studies, theses and dissertations.

2.3. Study Resources

The research was carried out in September 2020, updated in April 2021 in the following online databases: Medline, Embase, Cochrane, LILACS, IBECS, CRD and Epistemonikos.

2.4. Search Strategy and Data Extraction

The search was performed with the association of terms “Fibromyalgia”, “Positive Psychology”, “Cognitive Behavioral Therapy”, and their respective synonyms, with Boolean operators according to the most appropriate search strategy for each database.

Each study was initially evaluated by its title and abstract by two researchers, using the Rayyan system (, allowing the evaluator to be blinded to the other’s analysis. In case of disagreement, the study was analyzed by a third party.

After the analysis by title and abstract, the articles were fully read, and those that were not in accordance with the inclusion criteria were excluded. From those selected, the following data was extracted: type of study, objective population (number of people, sex and age), study duration, use of pharmacological therapy duration of cognitive behavioral therapy, use of other types of therapy, guidance received by patients, adherence to treatment, analysis of disease progression or regression and outcome. All data obtained were extracted by a researcher and revised by a second researcher, using an excel spreadsheet.

2.5. Quality of Studies and Risk of Bias

According to the Cochrane Recommendations Manual for Systematic Reviews [11], the quality of the work methodology, and the presence of biases in the included studies were analyzed by two independent reviewers using the HTA KMET (Standard Quality Assessment Criteria for Evaluating Primary Research Papers from a Variety of Fields) [12]. The selection of a representative sample of participants, the randomization of patients selected in the participating groups, the blinding of participants and researchers, a similar form of assessment for all groups, presence of incomplete data, selection of presented results, and other biases were evaluated. All studies were evaluated for each type of bias as low risk, high risk and doubtful risk and according to the probability of their bias, the studies as a whole were classified as low, medium or high risk. A study with low risk was one that was rated as having a low probability of bias in all of the biases analyzed. A moderate risk job was one that had 1 or 2 bias ratings as high or doubtful. Papers that had 3 or more assessments of high or doubtful biases were classified as high risk.

3. Results

3.1. Identification and Selection of Studies

A total of 1364 studies was analyzed. After excluding 296 duplicates and analyzing the title and abstract, a total of 110 articles were selected for full reading, of which 27 were included in the review. The distribution of articles can be seen in Figure 1.

Of the 2273 patients with fibromyalgia or strongly suspected of having fibromyalgia, according to primary studies, the majority were women, aged 18 years and over. In most studies, the average age was between 40 and 50 years old.

Figure 1. Article selection flowchart.

3.2. Characteristics of Included Studies

The earliest articles were published in 2002 [13] [14], and the most recent in 2019 were McCrae C. S. et al. 20119 [15] e Karlsson B et al. 2019 [16]. The majority of the studies were conducted in Spain (40.7%, n = 11) [13] [17] - [26], followed by the United States (29.6%, n = 8) [14] [15] [27] - [32], Holland (7.4%, n = 2) [33] [34], Sweden (7.4%, n = 2) [16] [35], Germany (3.7%, n = 1) [36], Brazil (3.7%, n = 1) [37], Canada (3.7%, n = 1) [38] and one shared study between Germany and the United States (3.7%, n = 1) [39], being “n” the number of articles.

Considering the 27 articles selected, all are randomized trials, due to the high level of evidence in the study design. The shortest studies lasted 3 months [27] [30] [31] [37] [38], on the other hand, the longest had duration of 3 years [21] [29]. Regarding the time of CBT, there was a variation of 4 weeks [14] [32] and 12 months [16].

3.3. Parameters and Medications Used by the Articles

In the articles analyzed, approximately 89 different parameters were utilized, such as methods of questionnaires, scales, clinical and laboratory tests, with the Fibromyalgia Impact Questionnaire (FIQ) being the most used (55.5%, n = 15) [13] [17] [18] [20] - [26] [30] [31] [37] [38] [39], followed by the Beck Depression Scale (BDI) (18.5%, n = 5) [13] [20] [23] [24] [27], the Short Form Health Survey Standardized Questionnaire 36 (SF-36) (14.8%, n = 4) [14] [23] [28] [32], the McGill Pain Questionnaire (14.8%, n = 4) [14] [15] [17] [26], the Hospital Anxiety and Depression Scale (HADS) (7.4%, n = 2) [18] [22] and the Anxiety Inventory (STAI) (7.4%, n = 2) [13] [37].

Different drug therapies were used in the analyzed articles, analgesics (n = 11) [13] [14] [17] [18] [19] [21] [23] [24] [29] [36] [37] and antidepressants (n = 9) [14] [15] [17] [18] [20] [25] [28] [30] [31], the most utilized. Followed by tricyclic antidepressants (n = 7) [13] [14] [21] [23] [24] [37] [39], anticonvulsants (n = 5) [18] [19] [25] [30] [31] and muscle relaxants (n = 3) [17] [18] [22].

3.4. CBT and Other Therapies

Of the 27 studies analyzed, only in 10 articles the patients had exclusive treatment with CBT [16] [19] [22] [23] [26] [27] [29] [32] [36] [39]. The most common association with CBT was the use of pharmacological treatment, evidenced in 8 of the studies [14] [15] [17] [21] [25] [28] [31] [35], followed by other therapies, in 6 studies [18] [20] [28] [30] [37] [38] the other association with physical exercise [13] [24] [33] [34].

Among the articles that exclusively used CBT as therapy, 7 showed improvement in pain [19] [22] [23] [26] [27] [32] [36], while 3 found no significant influence [16] [29] [39]; 6 recognized a positive emotional impact, with improvement in conditions such as depression and anxiety [16] [22] [27] [32] [36] [39], and only one did not show any change [23]. Three studies found an improvement in fatigue [16] [22] [23], one did not acknowledge any difference [36], and the other 6 did not specify it [19] [26] [27] [29] [32] [39]. In regards to sleep, two articles pointed to betterment [23] [29], while the other eight studies did not specify any changes in sleep [16] [19] [22] [26] [27] [32] [36] [39].

3.5. CBT and Fibromyalgia

Cognitive Behavioral Therapy was carried out exclusively through sessions with therapist psychologists, accompanied or not by specialist physicians, over specific periods. Some articles have supported therapy with other modalities of therapeutic techniques, such as standard pharmacological treatment and hypnosis [18].

In most articles, CBT sought to work on self-monitoring, self-knowledge, and cognitive restructuring exercises to reduce the intensity and regress the main FM symptoms [16].

Overall, 78.57% of the studies observed regression of at least one FM symptom, whether physical (such as pain, stiffness, sleep, and fatigue); or psychological (such as anxiety, stress, and depression). Questionnaires [19], pain scores [21], analysis of variance [36], and subjective clinical impressions [27] were implemented to analyze the improvement in fibromyalgia as the treatment with CBT evolved. The complications of these patients were not scruntinized by the articles analyzed. The articles details can be seen in Table 1.

3.6. Evaluation of the Quality of Articles

Of the 27 studies, 3 papers were at low risk [21] [28] [38]. 14 at moderate risk [13] [14] [15] [18] [19] [20] [24] [25] [26] [27] [30] [33] [34] [35], and 9 at high risk [16] [17] [22] [23] [31] [32] [36] [37] [39] as shown in Figure 2.

4. Discussion

4.1. Compliance

Patient compliance was analyzed based on attendance at sessions, completion of CBT treatment, and post-therapy follow-ups, with a mean percentage of complete adherence by the end of the research of 81.31% in 22 of the analyzed studies [13] [14] [15] [16] [17] [19] - [24] [26] [27] [28] [29] [30] [32] [33] [35] [36] [38] [39]. Lazaridou et al. (2017) [32] was the research with the highest compliance carried out with 16 participants, with 100% adherence. On the other hand, the research by Lami, M. J. (2018) [26] had 126 participants, of which only 57.14% completed the study. Despite the high overall compliance, even with more than half of the patients fully adhering to treatment, it conferred no connection with the success rates [14].

4.2. Pain

FM is a chronic disorder characterized by hyperalgesia, and CBT has a crucial mechanism in its reduction through the development of cognitive skills and

Table 1. Data of the articles included.

Figure 2. Quality of studies and risk of bias according to the Cochrane recommendations manual for systematic reviews.

distraction techniques, showing, in neuroimaging studies, a reduction in the degree of connectivity between areas of the cerebral cortex related to pain [32].

Some clinical outcomes observed significant associations between changes in brain connectivity and long-term gains [32]. There was less pain sensation and improved resistance in those patients who underwent CBT [30], and more than half of the participants achieved declines in pain scales. Results indicate that CBT contributes to shifts in pain processing, promoting considerable improvement in clinical distress over time [27].

Few studies have not shown an improvement in the clinical status of patients. Falcão et al. (2008) [37] observed that patients who underwent CBT reduced the use of analgesics, but without objectively improving pain. Plasma levels of neuropeptide substance P (related to pain and stress signaling) in women with fibromyalgia who underwent CBT were reduced by 33%. However, there were no changes in the patients’ state, and in some cases, the pain was considered even more significant after treatment with CBT [16]. CBT did not improve pain compared to control. However, there were immediate and clinically meaningful pain reductions in one-third of patients in both groups analyzed [15].

4.3. Fatigue and Insomnia

The study by Lera et al. (2009) [24] observed that the association of CBT and multidisciplinary treatment was only effective in patients with chronic fatigue. However, the multidisciplinary treatment improved the clinical picture of the other patients.

Regarding insomnia, the sleep pattern improved in patients who underwent CBT compared to the control group with the pharmacological treatment. Relaxation is a crucial component that enhances the effects of CBT on insomnia in patients with fibromyalgia. In addition, autogenic training alone showed positive effects on functional sleep disorders. Also, adding CBT content specifically targeted to treat chronic diseases resulted in significant improvements in primary insomnia in sleep disorders in patients with sleep problems and chronic pain, including fibromyalgia [18].

4.4. Cost-Effectiveness of Treatment

CBT is cost-effective when compared to pharmacological treatment (pregabalin + duloxetine), usual care groups, and FDA-recommended drugs [19].

4.5. Well-Being

CBT and pharmacological therapy have the potential to relieve FM symptoms. The first was superior in regards to anxiety and depression [20] [31] [37]. In addition, it improved the perception of clinical symptoms through an alteration of afferent pain signals, emotions, cognitions and anxiety reduction, with a significantly greater subjective impression of clinical improvement compared to controls [27].

CBT has been related to an improvement in quality of life in general, facilitating daily activities due to a decrease in functional limitation and improvement in morning stiffness [20] [22] [39].

In the study by Gelman et al. (2002) [13] it was achieved a better coexistence with pain and a better adaptation and acceptance of the disorder and, therefore, a better quality of life with the learning of cognitive-behavioral coping strategies in the group of patients who did CBT. Accepting the disease and managing stress are valuable tools for improving the quality of life. Additionally, patients in the CBT group had a positive effect on “life control” which was maintained 12 months after the start of treatment [35].

The study by Jensen et al. (2012) [27] evaluated the effect of cognitive-behavioral therapy on the cortical activation of the CNS through functional magnetic resonance in patients with FM. There was evidence of increased activation in the ventrolateral prefrontal cortex, responsible for executive cognitive control. In the clinical setting, the patients treated with CBT exhibited improvement in symptoms of depression and anxiety.

4.6. Medications, Comparison, and Association with CBT

When comparing CBT and pharmacological therapy in FM, CBT was proved to be superior, resulting in improved quality of life, reduced catastrophizing, and better pain acceptance [25]. Combined therapy improved pain, quality of life, and perception of social support compared to pharmacological therapy alone [21] [28] [31].

On the other hand, Garcia et al. (2006) [22] argues that CBT therapy associated with medications has not shown increased efficacy, and CBT alone would be more effective. The use of CBT for a limited time seems to be more effective and lasting than continuous pharmacological management, considering the side effects and the long-term cost [14] [22].

Patients in CBT had a lower rate of depression and higher scores in mental health compared to patients who used only pharmacological therapy, in addition to reducing the weekly use of acetaminophen for pain control. However, pharmacological therapy and CBT have shown similar results when dealing with symptoms of pain, anxiety, and quality of life [37].

4.7. Other Non-Pharmacological Therapies and CBT

Patients undergoing CBT in association with hypnosis showed significant improvement in the FIQ Total Score, a scale that assesses the impact of fibromyalgia (3.84, p < 0.01). There was a significant impact in patients undergoing CBT on the FIQ Total Score (t = 2.28; p < 0.05) [17].

CBT was more effective than pharmacological therapy in improving pain, stiffness, the number of tender points, catastrophizing, emotional stress, and sleep. The joining of hypnosis and CBT was even more effective [18]. Multidisciplinary therapy has led to better living with pain and better adaptation and acceptance in the short and long term [13].

The treatment effects of a combination of physical exercise and CBT in high-risk FM were significant for all primary outcomes, showing differences in physical (pain, fatigue, and functional disability) and psychological (negative mood, anxiety, and autonomy) functioning [33] [38].

On the other hand, Redondo et al. (2004) [23], also observed short-term clinical improvement, but without significant improvement one year after treatment. Exercise in association with motivational therapy increased physical capacity and improved clinical outcomes in patients who did not regularly use opioids. The study by Lera et al. (2009) [24] observed that the association of CBT with multidisciplinary treatment was only effective in patients with chronic fatigue. In other patients, only multidisciplinary treatment was effective in improving the clinical picture.

5. Conclusions

Cognitive Behavioral Therapy (CBT) has a great impact on the quality of life of patients, improving pain and fighting depression, anxiety, stress, rigidity, fatigue, and insomnia associated with the condition, facilitating daily activities and reducing functional limitations. Such improvement is maintained for a prolonged period after the end of treatment.

In addition to the monotherapeutic use, CBT can be associated with physical exercise, relaxation, psychological treatment, and hypnosis, presenting synergistic effects with each other.

CBT, despite being more cost-effective and more effective compared to drug therapy, can be used concomitantly with the latter, with analgesics and antidepressants being the most frequently used in the treatment.

Conflicts of Interest

The authors declare no conflicts of interest regarding the publication of this paper.


[1] Clauw, D.J. (2014) Fibromyalgia: A Clinical Review. JAMA, 311, 1547-1555.
[2] Hawkins, R.A. (2013) Fibromyalgia: A Clinical Update. Journal of Osteopathic Medicine, 113, 680-689.
[3] Vincent, A., Whipple, M.O. and Rhudy, L.M. (2016) Fibromyalgia Flares: A Qualitative Analysis. Pain Medicine, 17, 463-468.
[4] Thong, I.S.K., Tan, G. and Jensen, M.P. (2017) The Buffering Role of Positive Affect on the Association between Pain Intensity and Pain Related Outcomes. Scandinavian Journal of Pain, 14, 91-97.
[5] Casale, R., Sarzi-Puttini, P., Botto, R., Alciati, A., Batticciotto, A., Marotto, D., et al. (2019) Fibromyalgia and the Concept of Resilience. Clinical and Experimental Rheumatology, 37, 105-113.
[6] de Sousa Braz, A., de Paula, A.P., de Fátima Melo Diniz, M. and de Almeida, R.N. (2011) Uso da terapia não farmacológica, medicina alternativa e complementar na fibromialgia. Revista Brasileira de Reumatologia, 51, 275-282.
[7] Aman, M.M., Yong, R.J., Kaye, A.D. and Urman, R.D. (2018) Evidence-Based Non-Pharmacological Therapies for Fibromyalgia. Current Pain and Headache Reports, 22, Article No. 33.
[8] Bernardy, K., Füber, N., Köllner, V. and Häuser, W. (2010) Efficacy of Cognitive-Behavioral Therapies in Fibromyalgia Syndrome—A Systematic Review and Metaanalysis of Randomized Controlled Trials. The Journal of Rheumatology, 37, 1991-2005.
[9] Hassett, A.L. and Gevirtz, R.N. (2009) Nonpharmacologic Treatment for Fibromyalgia: Patient Education, Cognitive-Behavioral Therapy, Relaxation Techniques, and Complementary and Alternative Medicine. Rheumatic Disease Clinics of North America, 35, 393-407.
[10] Page, M.J., McKenzie, J.E., Bossuyt, P.M., Boutron, I., Hoffmann, T.C., Mulrow, C.D., et al. (2021) The PRISMA 2020 Statement: An Updated Guideline for Reporting Systematic Reviews. BMJ, 372, 9 p.
[11] Higgins, J.P.T., Altman, D.G., Gøtzsche, P.C., Jüni, P., Moher, D., Oxman, A.D., et al. (2011) The Cochrane Collaboration’s Tool for Assessing Risk of Bias in Randomised Trials. BMJ, 343, 9 p.
[12] Kmet, L.M., Lee, R.C. and Cook, L.S. (2004) Standard Quality Assessment Criteria for Evaluating Primary Research Papers from a Variety of Fields. Alberta Heritage Foundation for Medical Research, 13, 31 p.
[13] Gelman, S.M., Lera, S., Caballero, F. and López, M.J. (2002) Tratamiento multidisciplinario de la fibromialgia. Estudio piloto prospectivo controlado. Revista Española de Reumatología, 29, 323-329.
[14] Williams, D.A., Cary, M.A., Groner, K.H., Chaplin, W., Glazer, L.J., Rodriguez, A.M., et al. (2002) Improving Physical Functional Status in Patients with Fibromyalgia: A Brief Cognitive Behavioral Intervention. The Journal of Rheumatology, 29, 1280-1286.
[15] McCrae, C.S., Williams, J., Roditi, D., Anderson, R., Mundt, J.M., Miller, M.B., et al. (2019) Cognitive Behavioral Treatments for Insomnia and Pain in Adults with Comorbid Chronic Insomnia and Fibromyalgia: Clinical Outcomes from the SPIN Randomized Controlled Trial. Sleep, 42, Article ID: zsy234.
[16] Karlsson, B., Burell, G., Kristiansson, P., Björkegren, K., Nyberg, F. and Svärdsudd, K. (2019) Decline of Substance P Levels after Stress Management with Cognitive Behaviour Therapy in Women with the Fibromyalgia Syndrome. Scandinavian Journal of Pain, 19, 473-482.
[17] Castel, A., Salvat, M., Sala, J. and Rull, M. (2009) Cognitive-Behavioural Group Treatment with Hypnosis: A Randomized Pilot Trial in Fibromyalgia. Contemporary Hypnosis, 26, 48-59.
[18] Castel, A., Cascón, R., Padrol, A., Sala, J. and Rull, M. (2012) Multicomponent Cognitive-Behavioral Group Therapy with Hypnosis for the Treatment of Fibromyalgia: Long-Term Outcome. The Journal of Pain, 13, 255-265.
[19] Luciano, J.V., D’Amico, F., Cerdà-Lafont, M., Peñarrubia-María, M.T., Knapp, M., Cuesta-Vargas, A.I., et al. (2014) Cost-Utility of Cognitive Behavioral Therapy versus U.S. Food and Drug Administration Recommended Drugs and Usual Care in the Treatment of Patients with Fibromyalgia: An Economic Evaluation alongside a 6-Month Randomized Controlled Trial. Arthritis Research & Therapy, 16, Article No. 451.
[20] Parra-Delgado, M. and Latorre-Postigo, J.M. (2013) Effectiveness of Mindfulness-Based Cognitive Therapy in the Treatment of Fibromyalgia: A Randomised Trial. Cognitive Therapy and Research, 37, 1015-1026.
[21] Martín, J., Torre, F., Padierna, A., Aguirre, U., González, N., Matellanes, B., et al. (2014) Impact of Interdisciplinary Treatment on Physical and Psychosocial Parameters in Patients with Fibromyalgia: Results of a Randomised Trial. International Journal of Clinical Practice, 68, 618-627.
[22] García, J., Simón, M.A., Durán, M., Canceller, J., Aneiros, F.J. (2006) Differential Efficacy of a Cognitive-Behavioral Intervention versus Pharmacological Treatment in the Management of Fibromyalgic Syndrome. Psychology, Health & Medicine, 11, 498-506.
[23] Redondo, J.R., Justo, C.M., Moraleda, F.V., Velayos, Y.G., Puche, J.J.O., Zubero, J.R., et al. (2004) Long-Term Efficacy of Therapy in Patients with Fibromyalgia: A Physical Exercise-Based Program and a Cognitive-Behavioral Approach. Arthritis Care & Research, 51, 184-192.
[24] Lera, S., Gelman, S.M., López, M.J., Abenoza, M., Zorrilla, J.G., Castro-Fornieles, J., et al. (2009) Multidisciplinary Treatment of Fibromyalgia: Does Cognitive Behavior Therapy Increase the Response to Treatment? Journal of Psychosomatic Research, 67, 433-441.
[25] Alda, M., Luciano, J.V., Andrés, E., Serrano-Blanco, A., Rodero, B., del Hoyo, Y.L., et al. (2011) Effectiveness of Cognitive Behaviour Therapy for the Treatment of Catastrophisation in Patients with Fibromyalgia: A Randomised Controlled Trial. Arthritis Research & Therapy, 13, Article No. R173.
[26] Lami, M.J., Martínez, M.P., Miró, E., Sánchez, A.I., Prados, G., Cáliz, R., et al. (2018) Efficacy of Combined Cognitive-Behavioral Therapy for Insomnia and Pain in Patients with Fibromyalgia: A Randomized Controlled Trial. Cognitive Therapy and Research, 42, 63-79.
[27] Jensen, K.B., Kosek, E., Wicksell, R., Kemani, M., Olsson, G., Merle, J.V., et al. (2012) Cognitive Behavioral Therapy Increases Pain-Evoked Activation of the Prefrontal Cortex in Patients with Fibromyalgeia. Pain, 153, 1495-1503.
[28] Ang, D.C., Jensen, M.P., Steiner, J.L., Hilligoss, J., Gracely, R.H. and Saha, C. (2013) Combining Cognitive-Behavioral Therapy and Milnacipran for Fibromyalgia: A Feasibility Randomized-Controlled Trial. The Clinical Journal of Pain, 29, 747-754.
[29] McCrae, C.S., Mundt, J.M., Curtis, A.F., Craggs, J.G., O’Shea, A.M., Staud, R., et al. (2018) Gray Matter Changes Following Cognitive Behavioral Therapy for Patients with Comorbid Fibromyalgia and Insomnia: A Pilot Study. Journal of Clinical Sleep Medicine, 14, 1595-1603.
[30] Ang, D.C., Chakr, R., Mazzuca, S., France, C.R., Steiner, J. and Stump, T. (2010) Cognitive-Behavioral Therapy Attenuates Nociceptive Responding in Patients with Fibromyalgia: A Pilot Study. Arthritis Care & Research, 62, 618-623.
[31] Menga, G., Ing, S., Khan, O., Dupre, B., Dornelles, A.C., Alarakhia, A., et al. (2014) Fibromyalgia: Can Online Cognitive Behavioral Therapy Help? Ochsner Journal, 14, 343-349.
[32] Lazaridou, A., Kim, J., Cahalan, C.M., Loggia, M.L., Franceschelli, O., Berna, C., et al. (2017) Effects of Cognitive-Behavioral Therapy (CBT) on Brain Connectivity Supporting Catastrophizing in Fibromyalgia. The Clinical Journal of Pain, 33, 215-221.
[33] Van Koulil, S., Kraaimaat, F.W., Van Lankveld, W., Van Helmond, T., Vedder, A., Van Hoorn, H., et al. (2011) Cognitive-Behavioral Mechanisms in a Pain-Avoidance and a Pain-Persistence Treatment for High-Risk Fibromyalgia Patients. Arthritis Care & Research, 63, 800-807.
[34] Van Koulil, S., Van Lankveld, W., Kraaimaat, F.W., Van Helmond, T., Vedder, A., Van Hoorn, H., et al. (2010) Tailored Cognitive-Behavioral Therapy and Exercise Training for High-Risk Patients with Fibromyalgia. Arthritis Care & Research, 62, 1377-1385.
[35] Karlsson, B., Burell, G., Anderberg, U.M. and Svärdsudd, K. (2015) Cognitive Behaviour Therapy in Women with Fibromyalgia: A Randomized Clinical Trial. Scandinavian Journal of Pain, 9, 11-21.
[36] Thieme, K., Turk, D.C., Gracely, R.H. and Flor, H. (2016) Differential Psychophysiological Effects of Operant and Cognitive Behavioural Treatments in Women with Fibromyalgia. European Journal of Pain, 20, 1478-1489.
[37] Falcão, D.M., Sales, L., Leite, J.R., Feldman, D., Valim, V. and Natour, J. (2008) Cognitive Behavioral Therapy for the Treatment of Fibromyalgia Syndrome: A Randomized Controlled Trial. Journal of Musculoskeletal Pain, 16, 133-140.
[38] Langford, M.M. (2008) The Efficacy of a Combined Cognitive-Behavioural and Interpersonal Therapy Approach to the Treatment of Fibromyalgia Syndrome: A Randomized Controlled Trial. Doctor’s Thesis, University of Saskatchewan, Saskatoon.
[39] Thieme, K., Flor, H. and Turk, D.C. (2006) Psychological Pain Treatment in Fibromyalgia Syndrome: Efficacy of Operant Behavioural and Cognitive Behavioural Treatments. Arthritis Research & Therapy, 8, Article No. R121.

Copyright © 2022 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.